Healthcare
Monday, July 4, 2016
BRIEF-SpectraCure: Patent for dose evaluation approved in US
* The US Patent Office has approved patent relating to dose evaluation of SpectraCure
technology for treatment of prostate cancer with photodynamic tumor therapy (PDT)
Read more
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment